MedTrace Logo

Evaluation of Protective Effect of Activated Charcoal and Probiotic Against Progression of Chronic Kidney Disease

NCT05540431 · Status: UNKNOWN · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2022-09-14

No results posted yet for this study

Summary

Investigate the nephroprotective effect of Activated Charcoal and Probiotic in limiting the progression of renal impairment in patients with chronic kidney disease and improving of renal function test and phosphate level.

Condition or disease:

chronic kidney disease

Conditions

  • Uremic Toxin

Interventions

DRUG

Activated Charcoal

RCT

DIETARY_SUPPLEMENT

Probiotic

RCT

OTHER

No intervention

RCT

Sponsors & Collaborators

  • Waleed Khaild Rahman Kareem Al-kabi

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-09-25
Primary Completion
2023-09-20
Completion
2023-12-20

Countries

  • Iraq

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05540431 on ClinicalTrials.gov